[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
…, P Validire, B Besse, E Brambilla, C Brambilla… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
…, P Valagussa, A Rossi, G Tancini, C Brambilla… - Breast cancer research …, 1985 - Springer
The paper reviews all adjuvant studies carried out since 1973 at the Milan Cancer Institute
in women with resectable breast cancer and positive axillary nodes. The updated results …
in women with resectable breast cancer and positive axillary nodes. The updated results …
Combination chemotherapy as an adjuvant treatment in operable breast cancer
…, A Rossi, L Brugnatelli, C Brambilla… - … England Journal of …, 1976 - Mass Medical Soc
Prolonged cyclic combination chemotherapy with cyclophosphamide, methotrexate and
fluorouracil was evaluated as adjuvant treatment to radical mastectomy in primary breast cancer …
fluorouracil was evaluated as adjuvant treatment to radical mastectomy in primary breast cancer …
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer
…, B Solomon, E Brambilla, C Brambilla… - Science translational …, 2010 - science.org
Lung cancer remains one of the leading causes of cancer-related death in developed countries.
Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to …
Although lung adenocarcinomas with EGFR mutations or EML4-ALK fusions respond to …
American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
…, B Wallaert, CG Brambilla… - … of respiratory and …, 2002 - mayoclinic.elsevierpure.com
Despite the considerable progress in the classification of the idiopathic interstitial pneumonias
(IIPs), the lack of an international standard has resulted in variable and confusing …
(IIPs), the lack of an international standard has resulted in variable and confusing …
[HTML][HTML] Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer—the results of 20 years of follow-up
…, A Moliterni, M Zambetti, C Brambilla - … England Journal of …, 1995 - Mass Medical Soc
Background Adjuvant combination chemotherapy with cyclophosphamide, methotrexate,
and fluorouracil was administered after radical mastectomy for primary breast cancer with …
and fluorouracil was administered after radical mastectomy for primary breast cancer with …
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more
G Bonadonna, U Veronesi, C Brambilla… - JNCI: Journal of the …, 1990 - academic.oup.com
In 165 women with breast cancer who were candidates for mastectomy because the largest
diameter of the tumor was 3 cm or more, we administered primary chemotherapy in the …
diameter of the tumor was 3 cm or more, we administered primary chemotherapy in the …
Early detection of lung cancer: role of biomarkers
C Brambilla, F Fievet, M Jeanmart… - European …, 2003 - Eur Respiratory Soc
… Brambilla E, Gazzeri S. P53 pathway and lung cancer In: Brambilla E, Brambilla C, editors.
Fundamental biology and clinical managementM Dekker New-York, Basel, 1998; pp. 173–…
Fundamental biology and clinical managementM Dekker New-York, Basel, 1998; pp. 173–…
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
…, S Querings, S Ansén, E Brambilla, C Brambilla… - Cancer discovery, 2011 - AACR
Although genomically targeted therapies have improved outcomes for patients with lung
adenocarcinoma, little is known about the genomic alterations that drive squamous cell cancer (…
adenocarcinoma, little is known about the genomic alterations that drive squamous cell cancer (…